arrow
A

Andreas Glenthøj

Department of Hematology
H指数:25
被引数:2,584

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

EHA Guidelines on the management of children and adults with hemoglobin SC disease

欧洲血液学协会关于血红蛋白SC病患者儿童和成人管理的指南

2026-10-070
OAAI
Incidentally detected vertebral fractures and risk of myeloma: a prospective cohort study of 9059 CT-scanned Danish general population individuals

偶发检测的椎体骨折与骨髓瘤风险:一项对9059名接受CT扫描的丹麦普通人群的前瞻性队列研究

Leukemia
IF13.4
2026-09-180
OAAI
Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3trial

米塔匹泛在依赖输血的α-地中海贫血或β-地中海贫血成人中的有效性和安全性(ENERGIZE-T):一项双盲、随机、多中心、安慰剂对照、III期临床试验

2026-09-121
PRE
Comprehensive reanalysis of 2,040 undiagnosed clinical whole-genome sequencing cases improves diagnostic yield

对2,040例未诊断临床全基因组测序病例的全面再分析提高了诊断率

2026-08-110
OA
Clinical Heterogeneity and Outcome of acquired PRCA: a Multicenter European Study

临床异质性与获得性PRCA的结局:一项多中心欧洲研究

2026-05-280
OAAI
Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Hmpv in Haematological Malignancy, Insights From EpiCOVIDeha/Epiresha Registry

被低估、未接种疫苗、未治疗:一项关于血液系统恶性肿瘤患者Hmpv的多国登记分析,来自EpiCOVIDeha/Epiresha登记研究的见解

2026-02-270
OA
HELIOS Action: Advancing research, education, and equity in hemoglobinopathies across Europe and beyond

HELIOS行动计划:推动欧洲及全球范围的血红蛋白病研究、教育和公平。

2025-12-010
OAAI
Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS-COV-2-A Report From the EPICOVIDEHA/EPIRESEHA Registry
2025-12-010
OAAI
A structural deletion in the 3′UTR of SLC11A2 is associated with altered iron status: Evidence from two large Danish cohorts

SLC11A2基因3′UTR区域的缺失与铁状态改变相关:来自两个大型丹麦队列的证据

2025-10-170
OAAI
Mitapivat in adults with non-transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE): a phase 3, international, randomised, double-blind, placebo-controlled trial

米塔吡范(mitapivat)用于非输血依赖性α-地中海贫血或β-地中海贫血成人患者的治疗(ENERGIZE):一项III期、国际、随机、双盲、安慰剂对照试验

2025-06-190
PRE
COVID-19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNet
2025-04-160
OAAI
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023-2024: EPICOVIDEHA-EPIFLUEHA Report
2024-12-230
OAAI